● Recruiting

Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib + Abiraterone (PROceed)

Condition: Metastatic Castration-resistant Prostate Cancer · Sponsor: AstraZeneca

PhaseN/A

Planned participants250

Who can joinMale, 18 Years to no upper limit

Healthy volunteersNo

About this study

PROceed is a multisite, prospective, observational study that describes the real-world use and clinical experience of mCRPC patients treated with the combination of olaparib and abiraterone in the mCRPC setting. Clinical outcomes will be assessed in patients who are either NHA-naive or NHA-exposed prior to initiating olaparib + abiraterone treatment, respectively. Patient demographic and clinical characteristics, as well as treatment received prior and subsequent to olaparib + abiraterone, will also be described. The study plans to enroll patients for a maximum of 2 years and follow up patients from initiation of olaparib until 1 year post last patient in.

This description comes directly from the study's public registry record.

Talk to the study team

AstraZeneca Clinical Study Information Center · 1-877-240-9479 · information.center@astrazeneca.com

Always discuss trial participation with your own doctor first.

Locations (34)

Research Site	Aschaffenburg, Germany	Recruiting
Research Site	Augsburg, Germany	Recruiting
Research Site	Bergisch Gladbach, Germany	Recruiting
Research Site	Berlin, Germany	Recruiting
Research Site	Bonn, Germany	Recruiting
Research Site	Cologne, Germany	Recruiting
Research Site	Dresden, Germany	Recruiting
Research Site	Duisburg, Germany	Recruiting
Research Site	Eisenach, Germany	Recruiting
Research Site	Eisleben Lutherstadt, Germany	Recruiting
Research Site	Frankfurt, Germany	Recruiting
Research Site	Greifswald, Germany	Recruiting

+ 22 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06380738